See more : VIRIDIEN (CGGYY) Income Statement Analysis – Financial Results
Complete financial analysis of Fairchem Organics Limited (FAIRCHEMOR.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Fairchem Organics Limited, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Invesco Perpetual Select Trust plc – UK Equity Share Portfolio (IVPU.L) Income Statement Analysis – Financial Results
- Couchbase, Inc. (BASE) Income Statement Analysis – Financial Results
- Kirloskar Oil Engines Limited (KIRLOSENG.BO) Income Statement Analysis – Financial Results
- CHP Merger Corp. (CHPMW) Income Statement Analysis – Financial Results
- FLORA TEXTILES LTD. (FLORATX.BO) Income Statement Analysis – Financial Results
Fairchem Organics Limited (FAIRCHEMOR.BO)
About Fairchem Organics Limited
Fairchem Organics Limited manufactures and sells specialty oleo chemicals and intermediate nutraceuticals in India, East Asia, the Middle East, and North America. It provides nutraceuticals comprising natural and mixed tocopherol and sterol concentrates; and oleo chemicals, such as dimer, monobasic, linoleic/soya fatty, monomer, palmitic, and distilled fatty acid products, as well as residues. The company was incorporated in 2019 and is based in Ahmedabad, India. Fairchem Organics Limited operates as a subsidiary of FIH Mauritius Investments Ltd.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 6.18B | 6.47B | 6.42B | 3.96B | 3.06B |
| Cost of Revenue | 5.05B | 4.96B | 4.65B | 2.70B | 2.11B |
| Gross Profit | 1.13B | 1.51B | 1.78B | 1.25B | 945.33M |
| Gross Profit Ratio | 18.26% | 23.30% | 27.65% | 31.69% | 30.91% |
| Research & Development | 1.63M | 1.95M | 1.94M | 1.54M | 2.60M |
| General & Administrative | 44.01M | 29.56M | 21.54M | 70.69M | 25.30M |
| Selling & Marketing | 73.68M | 71.66M | 72.02M | 59.15M | 38.28M |
| SG&A | 117.69M | 101.22M | 93.57M | 129.84M | 63.57M |
| Other Expenses | 1.01B | 4.97M | 513.00K | 62.00K | 1.19M |
| Operating Expenses | 1.13B | 865.02M | 797.41M | 631.58M | 518.12M |
| Cost & Expenses | 5.62B | 5.83B | 5.44B | 3.34B | 2.63B |
| Interest Income | 423.00K | 124.00K | 373.00K | 2.31M | 1.25M |
| Interest Expense | 42.39M | 62.62M | 68.56M | 69.78M | 65.79M |
| Depreciation & Amortization | 92.78M | 81.52M | 71.31M | 65.73M | 59.60M |
| EBITDA | 681.14M | 729.68M | 1.05B | 688.06M | 548.59M |
| EBITDA Ratio | 11.02% | 11.29% | 16.37% | 17.45% | 18.07% |
| Operating Income | 582.14M | 649.99M | 985.22M | 624.78M | 423.93M |
| Operating Income Ratio | 9.42% | 10.05% | 15.34% | 15.79% | 13.86% |
| Total Other Income/Expenses | -36.18M | -64.06M | -65.78M | -69.17M | -3.03M |
| Income Before Tax | 545.96M | 585.93M | 912.40M | 555.61M | 424.18M |
| Income Before Tax Ratio | 8.83% | 9.06% | 14.21% | 14.04% | 13.87% |
| Income Tax Expense | 140.96M | 150.91M | 233.34M | 130.76M | 77.14M |
| Net Income | 405.00M | 435.02M | 679.06M | 424.85M | 347.04M |
| Net Income Ratio | 6.55% | 6.72% | 10.57% | 10.73% | 11.35% |
| EPS | 31.10 | 33.41 | 52.15 | 32.63 | 26.65 |
| EPS Diluted | 31.11 | 33.41 | 52.15 | 32.63 | 26.65 |
| Weighted Avg Shares Out | 13.02M | 13.02M | 13.02M | 13.02M | 13.02M |
| Weighted Avg Shares Out (Dil) | 13.02M | 13.02M | 13.02M | 13.02M | 13.02M |
Source: https://incomestatements.info
Category: Stock Reports